Experiments in murine ARDS models demonstrate the utility of pyridostigmine and α7-nACh-R agonists to reduce lung and systemic inflammation as well as mortality (Su et al. 2010; Pinheiro et al. 2021; Bricher Choque et al. 2021). This evidence concerns the gene CHRNA7 and acute respiratory distress syndrome.